Keyphrases
Long COVID
66%
Long COVID Symptoms
56%
St. George's Respiratory Questionnaire
50%
Media Differences
50%
Nontuberculous Mycobacterial Lung Disease
50%
6-minute Walk Test (6MWT)
50%
Vaccination
50%
Japanese Patients
50%
COVID-19 Vaccination
50%
Autosomal Dominant Cutis Laxa
50%
Elastin Gene
50%
Borg Scale
33%
6-minute Walk Distance (6MWD)
33%
Minimum Inhibitory Concentration Assay
25%
Forced Vital Capacity
25%
Pulmonary Function Test
25%
Clofazimine
20%
Clinical Parameters
16%
Alopecia
16%
Forced Expiratory Volume in 1 Second (FEV1)
16%
C-reactive Protein
16%
Dyspnea
16%
Lung Attenuation
14%
Middlebrook 7H9
12%
Broth Media
12%
Intrapulmonary Lesions
10%
Immunocompetent Woman
10%
Diagnostic Predictors
9%
University Hospital
8%
Life Functioning
8%
COVID-19 Impact
8%
Keio University
8%
Clinically Significant
8%
Sleep Disturbance
8%
Myalgia
8%
Chronic Course
8%
Patient Condition
8%
Long-term Exercise
8%
Subgroup Analysis
8%
Japan
8%
Pulmonary Function
8%
Dyspnea on Exertion
8%
Headache
8%
Third Dose
8%
Clinical Indicators
8%
COVID-19
8%
Healthcare Environment
8%
Muscle Weakness
8%
Blood Test
8%
Krebs Von Den Lungen-6 (KL-6)
8%
Medicine and Dentistry
Interstitial Lung Disease
50%
Mycobacterium Avium Complex
50%
Bronchoalveolar Lavage Fluid
50%
Amikacin
50%
Disease
50%
Diagnosis
50%
Biological Marker
50%
Exon
50%
Frameshift Mutation
50%
Small Airway Disease
50%
Autosomal Dominant Inheritance
50%
Elastin
50%
Cutis Laxa
50%
Computer Assisted Tomography
28%
Neutrophil
22%
Liposome
21%
Aminoglycoside
21%
Expiratory Reserve Volume
21%
Lung
21%
Lung Function Test
21%
Clofazimine
20%
Lung Lesion
14%
Function Test
14%
Residual Volume
14%
Lymphocyte
13%
Forced Vital Capacity
11%
High-Resolution Computed Tomography
9%
Idiopathic Interstitial Pneumonia
9%
CD8 Antigen
9%
Leukocyte
9%
Overexertion
8%
Sputum
7%
Intravenous Drug Administration
7%
Case Presentation
7%
Quantitative Computed Tomography
7%
Elastic Fiber
7%
Total Lung Capacity
7%
Connective Tissue Disease
7%
Bronchiectasis
7%
Outpatient
7%
Exome Sequencing
7%
Emphysema
7%
Asthma
7%
Extracellular Matrix
7%
Pharmacology, Toxicology and Pharmaceutical Science
Symptom
100%
Interstitial Lung Disease
50%
Disease
50%
Amikacin
50%
Minimum Inhibitory Concentration
50%
Vaccination Policy
50%
Mycobacterium Avium Complex
50%
Prospective Cohort Study
50%
Biological Marker
50%
Aminoglycoside
21%
Liposome
21%
SARS Coronavirus
16%
Interstitial Pneumonia
13%
Alopecia
12%
Dyspnea
12%
Overexertion
10%
CD8 Antigen
9%
Microorganism
7%
Disease Course
6%
Erethism
6%
Muscle Weakness
6%
Headache
6%
Myalgia
6%
Sleep Disorder
6%
Deterioration
6%
